In November 2018, BioDtech Inc was acquired by CytoBioscience located in San Antonio and itself an SBIR involved firm previously doing business (until Dec 2016) as Cytocentrics. The acquiring firm makes instruments used to screen if and how cells might react to drugs. 8ioDtech, Inc. is a biotechnology company developing and marketing products for the detection, neutralizaiton, and removal of endotoxin. Through an exclusive license from the National University of Singapore, BioDtech has been able to develop superior products for the endotoxin-related market. The technology developed by BioDtech has applications in the biopharmaceutical, medical device, medical, and food markets. Offerings include various detection solutions, including EndoDtec-F, a reagent that is used to uncover bacteria in environmental samples, injectable drugs, and medical devices, as well as on surfaces; sushi Î3 anti-sera that allows investigators to perform independent ELISA and western blot studies; and EndoPrep, a sample treatment system to remove the inhibitory or enhancing effects of proteins, peptides, and antibodies in endotoxin assays. The company also provides EndoBind-R, a removal reagent that removes endotoxins from aqueous samples; EndoZap-R, an endotoxin neutralization peptide that is used as an anti-microbial; endotoxin-free water; and endotoxin detection and removal services.
